£2.6M
The pre-seed round was co-led by IQ Capital and Ahren Innovation Capital to support team expansion and technology validation.
O
OxDX
OxDX develops AI powered rapid diagnostic technology for infectious diseases.
Oxford, UK
£2.6MTotal raised
OxDX is a University of Oxford spin out developing rapid pathogen testing technology that combines super resolution microscopy and machine learning. The platform aims to identify viruses, bacteria and other infectious agents within seconds.
Categories
Team
AB
Alex Batchelor
Chief Executive Officer